Semler Scientific, INC Form 4 insider transactions
Strive, Inc. and Semler Scientific, Inc. announce a proposed business combination, detailing associated risks and procedural requirements for the merger.
Strive, Inc. and Semler Scientific, Inc. issued a communication via X.com regarding their proposed business combination.
Strive CEO Matthew Cole posted on X.com regarding the proposed business combination with Semler Scientific, Inc., prompting an SEC filing.
Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive's CEO and CFO communicating details on X.com.
Strive, Inc. and Semler Scientific, Inc. announce a proposed business combination, outlining associated risks and future steps.
Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive filing a Form 425 related to the merger.
Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with further details to be filed with the SEC.
Strive's CFO posted on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and regulatory filings.
Strive's Chief Risk Officer shared an update on X.com concerning the company's proposed business combination with Semler Scientific.
Strive's CFO, Ben Pham, posted on X.com regarding the proposed business combination with Semler Scientific, emphasizing forward-looking statements and regulatory disclosures.
Strive's CFO, Ben Pham, posted on X.com regarding the company's proposed business combination with Semler Scientific, Inc. on September 22, 2025.
Strive, Inc.'s CFO posted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.
Strive's CFO, Ben Pham, issued a cautionary statement regarding the proposed business combination with Semler Scientific, highlighting inherent risks and uncertainties.
Strive's CFO, Ben Pham, communicated on X.com regarding the proposed business combination with Semler Scientific, emphasizing cautionary forward-looking statements.
Strive's CFO posted on X.com regarding the proposed business combination with Semler Scientific, emphasizing the ongoing process and regulatory filings.
Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, emphasizing forward-looking statements and associated risks.
Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, highlighting anticipated benefits and associated risks.
Strive's Chief Marketing Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.
Strive, Inc. filed a Form 425 regarding its proposed business combination with Semler Scientific, Inc., highlighting associated risks and regulatory steps.
Semler Scientific announced a merger with Strive, Inc., creating a combined entity focused on preventative healthcare and a significant Bitcoin treasury.
Semler Scientific, a medical device company, has entered into a definitive merger agreement with Strive, Inc., where Semler Sci shareholders will receive 21.05 shares of Strive Class A common stock for each Semler Sci share.
Strive, Inc. will acquire Semler Scientific in an all-stock transaction, creating a combined entity with over 10,900 Bitcoin and a focus on preventative diagnostics.
Semler Scientific's CEO, Douglas Murphy-Chutorian, exercised stock options and subsequently sold a portion of the acquired shares to cover costs, while also gifting shares to a family trust.
Semler Scientific, Inc. Director Natalie Brunell was granted 1,125 stock options with an exercise price of $41.04, vesting over six months.
Semler Scientific, Inc. Director Eric Semler exercised stock options to acquire 6,750 shares of common stock at $23.32 per share, increasing his direct beneficial ownership.
Semler Scientific's Chief Financial Officer, Renae Cormier, exercised stock options for 3,746 shares and subsequently transferred them to a family revocable trust, maintaining beneficial ownership.
Natalie Brunell, a director at Semler Scientific, Inc., acquired stock options on May 15, 2025, as reported in a Form 4 filing with the SEC.
Renae Cormier, CFO of Semler Scientific, Inc., reports the acquisition of stock options.
Director Eric Semler acquired stock options in Semler Scientific, Inc. on May 2, 2025.
Douglas Murphy-Chutorian, CEO of Semler Scientific, Inc., reports the acquisition of stock options.